Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | AMT-116 |
Synonyms | |
Therapy Description |
Limited information is currently available on AMT-116, a putative chimeric antigen receptor (CAR) T-cell therapy (Apr 2023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AMT-116 | AMT116|AMT 116 | Limited information is currently available on AMT-116, a putative chimeric antigen receptor (CAR) T-cell therapy (Apr 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05725291 | Phase Ib/II | AMT-116 | AMT-116 in Patients With Selected Advanced Solid Tumors | Recruiting | AUS | 0 |